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ABSTRACT 
Each year, more than half a million women are diagnosed with cervical cancer, resulting 
in about 300,000 deaths a year. In Macedonia cervical cancer is second most common 
according to the prevalence of malignant neoplasms in women. The most common and 
most studied cause is Human Papillomavirus (HPV). For the research were used 
statistical materials obtained from Center for Public Health – Kocani and State Statistical 
Office of R. Northern Macedonia.  For the collected data from the organized screening on 
the territory of Kocani, Vinica, Berovo, Pehchevo and Delchevo for the period 2016-2020, 
as well as reported outpatient polyclinic morbidity for the same territory in a period of 
10 years, ie from 2011 – 2020, was used statistical method. Screening with Pap smear is 
the best method to decrease the number of cervical cancer diseased and decrease 
mortality. Preliminary results from new immunotherapy approaches show promising 
results for overall survival. The main purpose of this research is to point out the 
importance of regular examinations and screening for early detection of cervical changes, 
prevention of invasive forms of cancer, and timely treatment. 
Keywords: Cervix, Cancer, HPV, Screening, Prevention 
1. INTRODUCTION
 Cervical cancer remains a public health problem worldwide as it is 
responsible for the lives of approximately 300,000 women per year. In highly 
developed countries there are effective methods for early detection of 
precancerous lesions by cytology (PAP smear). Due to the weak health system, as 
well as limited resources for screening and treatment, the highest percentage of 
deaths are in undeveloped and in developing countries. It usually affects women 
who are in the reproductive and working period of life. The percentage of deaths 
can be avoided especially because there is a lot of evidence that cervical cancer is 
one of the most preventable forms of cancer and with a good prognosis if 
detected early and treated effectively (World Health Organization, 2014).   
        The primary cause of precancerous changes and squamous cell carcinoma is 
asymptomatic persistent or chronic infection with high-risk HPV type 
(oncogenic). The highest prevalence of high-risk HPV type is observed in young 
people and death from cervical cancer reaches a peak in the period of 40-50 years 
of age. Factors that can increase the risk of HPV infection and thus the 
development of cancer are having multiple partners as well as a partner who has 
had multiple partners. Although in the majority of cancers, the cause is mainly 
high-risk HPV infection, the presence of HPV does not always mean that the 
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condition will progress to cancer. In fact, most women infected with HPV will not 
develop cancer regardless of the type of virus, because the virus lives short and the 
body eliminates it spontaneously over a period of two years. The infection persists 
in only a small percentage of women, of whom a small percentage develop 
precancerous lesions, and an even smaller percentage of them will progress to 
invasive cancer. There are cofactors which allow HPV infection to persist and 
progress to cancer. Тhe most common of them are co-infection with other sexually 
transmitted agents such as herpes simplex, gonorrhea, chlamydia, parity and early 
age of first pregnancy, smoking, genetic factors, circumcision of the partner, use of 
oral contraceptives for more than five years, HPV type, immune status and other. It 
is important to note that the absence of HPV does not mean the absence of disease. 
All of the above factors not only condition the persistence of HPV infection, but also 
in the absence of infection, contribute to cervical changes. Unfortunately, most 
women remain asymptomatic until the disease progresses, especially women who 
are not sexually active at the time. Early symptoms include: increased bad-smelling 
vaginal discharge, irregular bleeding in women of childbearing potential, postcoital 
point bleeding, postmenopausal bleeding. Specific symptoms are not always 
present, but changes such as erythroplakia and leukoplakia will be seen on routine 
examination. When the disease has progressed and the tumor has spread to the 
surrounding organs and tissues, then symptoms characteristic of the affected 
tissues occurs. As the process deepens in the cervix, the bleeding becomes heavier 
and there is pain in the lower back, spine and legs. If the bladder is involved, the 
patient will have a feeling of urgency, dysuria, polyuria, hematuria. 
The primary method by which changes can be detected as a result of high-risk 
HPV is PAP test. PAP is a screening tool that requires changes in the transformation 
zone and often those changes are caused by HPV. But not every woman who gets a 
positive screening test actually has cervical cancer. Additional diagnostic tests are 
performed after screening to confirm or rule out the diagnosis. Colposcopy, biopsy, 
and endocervical curettage are the most commonly used methods for diagnosing 
cervical cancer. Treatment should be individualized for each patient. The treatment 
plan is best to make a team of gynecologists, oncologists and radiotherapy 
specialists. Options for treating invasive cancer include surgery, radiotherapy, 
chemotherapy, or a combination of these. Early detection methods, in addition to 
cytology, include visual inspection of the cervix with Schiller test and acetoacetic 
acid staining and HPV DNA testing and typing. Lesions that are cytologically 
detected are CIN-marked cervical intraepithelial neoplasms and can be mild to 
dysplasia (CIN1), moderate (CIN2), severe (CIN3), or carcinoma in situ (CIS). 
Prevention and control programs are most important and designed to reduce 
incidence, morbidity and mortality. Aref-Adib, M., Freeman-Wang, T., (2016), 
Bansal, A., Singh, M., Rai, B. (2016), Barek, С. J. (2011), Barret, K. E., Barman, S. M., 
Boitano, S., Brooks, H. L. (2012), Burd, E. M., (Jan., 2003), Dimitrov, G., Sterjovska - 
Aleksovska, A., (2013), Hurt, K. J., Guile, M. W., Bienstock, J. L., Fox, H. E., Wallach, E. 
(2010), Jovanovski D., Maneva-Kostovska, L., Anastasova-Nikolova L., Smickoska, S., 
Krstevska, V., (2002), Kumar, V., Abbas, A. K., Aster, J. C. (2015), Ministry of Health 
of the Republic of Northern Macedonia. Guidelines for practicing evidence-based 
medicine (n.d.), Mladenovic, D. Et al. (2008), Palchevski, G. (1981). 
 
2. MATERIAL AND METHODS 
To achieve the objectives of this research, a statistical method of analysis was 
used on to collected data from the organized screenings on the territory of Kocani, 
Vinica, Berovo, Pehchevo and Delchevo for the period 2016-2020, as well as 
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reported outpatient - polyclinic morbidity for the same territory in a period of 10 
years, ie from 2011 - 2020. 
The statistical materials were obtained from the Center for Public Health - 
Kocani and the State Statistical Office of the Republic of Macedonia. 
 
3. RESULTS AND DISCUSSION 
In the research are processed the results of the conducted cervical cancer 
screenings on the territory of Kocani, Vinica, Berovo, Pehchevo and Delchevo for the 
period 2016-2020. 
According to the Program for early detection of malignant diseases in the 
Republic of Northern Macedonia, at the national level, screening is performed by 
gynecologists from private health institutions in accordance with preventive 
measures prescribed by the HIF, and refers to women who have selected a 
gynecologist and followed the procedure for gynecological examination, taking on a 
swab, preparation and delivery of the material for cytological analysis.  
The target group for screening are women aged 24-60. The recommended time 
interval for screening is 3 years. A still high percentage of women have limited 
access or no access to the Organized Screening Program at all because there are no 
gynecologists in their municipalities or there are not enough registered 
gynecologists. According to the Program for early detection of malignant diseases in 
the Republic of Macedonia for 2016 and the activities provided by the Program for 
Early Detection and Prevention of Cervical Cancer in the Republic of Macedonia, the 
screening was intended to cover women aged 36-45, as well as women aged 24-60 
who did not have a PAP test during 2015. 
 
Table 1 Results from the organized screening in 2016 
* Percentage refers to women who received a screening invitation in 2016  


















Number of invited women  81 
   
654 232 206 356 1529 
No. of returned invitations 0 
   
1 2 1 0 4 
No. to women who have received 
invitations 
81 
   
653 230 205 356 1525 
Received an invitation and did not call 
for an examination 
0 
   
47 16 0 9 72 
% Of women who received an invitation 
but did not appear for an examination 
0.0% 
   
7.2% 7.0% 0.0% 2.5% *5% 
No. on examined / performed PAP tests 81 
   
606 319 447 464 1917 
% Of women who received an invitation 
and called for an examination (had a 
Pap smear) 
100.0% 
   
92.8% 138.7% 218.0% 130.3% *127.1% 
Cytologically analyzed swabs 81 
   
532 293 306 499 1711 
Number of detected epithelial cell 
abnormalities 
0 
   
9 4 12 48 73 
% Of detected epithelial cell 
abnormalities from examined women 
0.0% 
   
1.5% 1.3% 2.7% 10.3% 4.0% 
% Of detected epithelial cell 
abnormalities from cytological smears 
0.0% 
   
1.7% 1.4% 3.9% 9.6% 4.5% 
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Chart 1 Discovered cell abnormalities in women aged 36-45 
 
According to the data from the Center for Public Health in Kocani, 654 
invitations were sent for screening of women aged 36-45, an age group that in 2016 
was to do a PAP test according to the Program for early detection of malignant 
diseases in the Republic of Northern Macedonia. 5% of those who received an 
invitation did not attend the examination. 1630 swabs from this age group were 
cytologically analyzed and 73 cellular abnormalities were detected. This means that 
the percentage of positive tests is 4.5, and 95.5% of the tests are negative. Of the 
abnormalities detected, the most common findings are HPV, ASC - US and CIN1. 25 
cases of HPV, 24 cases of ASC - US, 16 cases of CIN1, 5 cases of CIN2 and 3 cases of 
ASC - H. No invasive forms of cancer were detected. The percentage of cellular 
abnormalities is given in Chart 1. 
          
Table 2 Results from the organized screening in 2017 
 










Number of invited women 260 626 246 813 1945 
No. of returned invitations 2 1 0 0 3 
No. to women who have received 
invitations 
255 625 246 813 1939 
They received an invitation and did 
not call for an examination 
3 139 55 387 584 
% Of women who received an 
invitation but did not appear for an 
examination 
1.2% 22.2% 22.4% 47.6% 30.1% 
No. on examined / performed PAP 
tests 
257 486 191 426 1360 
% Of women who received an 
invitation and called for an 
examination (had a Pap smear) 
100.8% 77.8% 77.6% 52.4% 70.1% 
Cytologically analyzed swabs 200 390 177 421 1188 
Number of detected epithelial cell 
abnormalities 
12 16 5 7 40 
% Of detected epithelial cell 
abnormalities from examined women 
4.7% 3.3% 2.6% 1.6% 2.9% 
% Of detected epithelial cell 
abnormalities from cytological smears 
6.0% 4.1% 2.8% 1.7% 3.4% 
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The screening in 2017 continues with women aged 46 to 60 years. Table 2 gives 
results for this age group, and doesn’t include the age group of 36-45 years who in 
the previous year, in 2016, did not take a PAP test. According to the data from the 
CPH - Kocani, in 2017 there were no women who didn’t do the screening in the 
previous year, but 361 PAP tests were reported, and 339 cytologically analyzed 
swabs. From these swabs were detected 63 cytological abnormalities or 18.6%. 
These data are not included in the 2017 screening statistics.  
During 2017, 1945 invitations were sent, of which only 3 were returned. As 
many as 584 or 30.1% of women who received an invitation did not attend the 
examination, compared to 2016 when only 5% did not attend the examination. 1360 
PAP tests were performed, 1188 swabs were cytologically analyzed. Of those 3.4% 
are positive findings or 40 detected cellular abnormalities. 
 
 
Chart 2 Discovered cell abnormalities in women aged 46-60 
 
From the detected abnormalities, the most common are ASC - US, 14 cases, ASC - H 
8 cases where a high-risk lesion cannot be ruled out, and HPV with 7 cases. 4 swabs 
are positive for CIN1 and 1 for CIN2, as well as 1 positive for another malignant 
neoplasm. In 2017, the five most common findings are the same as in 2016, but the 
percentage of high-risk lesions (ASC-H) has increased. 
 
Table 3 Results from the organized screening in 2018 










Number of invited women 378 532 404 323 1637 
No. of returned invitations 0 0 0 0 0 
No. to women who have received 
invitations 
378 532 404 323 1637 
They received an invitation and did 
not call for an examination 
127 128 54 44 353 
% Of women who received an 
invitation but did not appear for an 
examination 
33.6% 24.1% 13.4% 13.6% 21.6% 
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No. on examined / performed PAP 
tests 
251 404 350 279 1284 
% Of women who received an 
invitation and called for an 
examination (had a Pap smear) 
66.4% 75.9% 86.6% 86.4% 78.4% 
Cytologically analyzed swabs 216 328 323 230 1097 
Number of detected epithelial cell 
abnormalities 
5 9 13 5 32 
% Of detected epithelial cell 
abnormalities from examined women 
2.0% 2.2% 3.7% 1.8% 2.5% 
% Of detected epithelial cell 
abnormalities from cytological smears 
2.3% 2.7% 4.0% 2.2% 2.9% 
 
The screening program in 2018 covers women aged 24-35. In 2018, women 
aged 46-60 in 2018 who in the previous year (2017) did not have a PAP test were 
not invited and examined. However, the CPH - Kocani has data on 299 PAP smears 
and 203 cytologically analyzed swabs. Cytological analyzes revealed 2 abnormal 
results. 1637 women have been invited and no invitations have been returned. 
21.6% of the women who received an invitation did not attend the examination, 
which is a decrease compared to the previous year, when 30.1% received an 
invitation and did not attend the examination.  
The number of PAP tests examined / performed is 1284, 1097 swabs were 
cytologically analyzed. Of these, epithelial cell abnormalities were detected in 2.9% 
or 32 cases, which is a decrease compared to 2017 when the percentage of positive 
from analyzed was 3.4%. 
Chart 3 shows the detected cellular abnormalities. The highest percentage are 
HPV infections - 11 cases, followed by ASC-US 8 cases. The screening in 2018 
revealed 3 findings of atypical glandular cells that require further investigation. 
 
 
Chart 3 Discovered cell abnormalities in women aged 24-35 
 
Table 4 Results from the organized screening in 2019 
 












Number of invited women 525 646 276 473 1920 
No. of returned invitations 0 7 0 0 7 
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No. to women who have received 
invitations 
525 639 276 473 1913 
They received an invitation and did 
not call for an examination 
207 178 59 82 526 
% Of women who received an 
invitation but did not appear for an 
examination 
39.4% 27.9% 21.4% 17.3% 27.5% 
No. on examined / performed PAP 
tests 
318 461 217 391 1387 
% Of women who received an 
invitation and called for an 
examination (had a Pap smear) 
60.6% 72.1% 78.6% 82.7% 72.5% 
Cytologically analyzed swabs 244 426 165 349 1184 
Number of detected epithelial cell 
abnormalities 
14 38 12 12 76 
% Of detected epithelial cell 
abnormalities from examined women 
4.4% 8.2% 5.5% 3.1% 5.5% 
% Of detected epithelial cell 
abnormalities from cytological smears 
5.7% 8.9% 7.3% 3.4% 6.4% 
 
The screening in 2019 is conducted for women aged 36-45 years. The data do 
not include women who took the PAP test in 2018. In 2019, the number of invited 
women is 1920, the number of returned invitations is 7. The number of women who 
received an invitation but did not appear for an examination is 526 or 27.5%, 
showing an increase compared to the previous year. 1387 PAP tests were performed 




Chart 4 Discovered cell abnormalities in women aged 36-45 
 
The most common findings are ASC - US with 33 cases, 30 cases with HPV, 3 
findings with ASC - H and adenocarcinoma in situ. 4 findings of CIN1 and 1 CIN2 
each, cervical adenocarcinoma and other malignant neoplasm. In 2019, in the age 
group of 36-45 years, the finding of invasive lesions increased compared to the 
screening in 2016, when there were no invasive forms in the detected cellular 
abnormalities. 
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Table 5 Results from the organized screening in 2020 
 










Number of invited women 665 373 125 199 1362 
No. of returned invitations 3 0 0 0 3 
No. to women who have received 
invitations 
662 373 125 199 1359 
They received an invitation and did not 
call for an examination 
258 107 13 36 414 
% Of women who received an invitation 
but did not appear for an examination 
39.0% 28.7% 10.4% 18.1% 30.5% 
No. on examined / performed PAP tests 405 266 112 127 910 
% Of women who received an invitation 
and called for an examination (had a 
Pap smear) 
61.2% 71.3% 89.6% 63.8% 67.0% 
Cytologically analyzed swabs 277 214 71 133 695 
Number of detected epithelial cell 
abnormalities 
15 13 5 8 41 
% Of detected epithelial cell 
abnormalities from examined women 
     
% Of detected epithelial cell 
abnormalities from cytological smears 
5.4% 6.1% 7.0% 6.0% 5.9% 
 
In 2020, 1362 women aged 46-61 were called for screening, and only 3 
invitations were returned. 414 women received an invitation, but did not respond 
to the examination or in percentages of 30.5%, which is the highest percentage 
during the 5 years from 2016-2020 when the screening was organized. 910 PAP 
tests were performed, of which 695 were cytologically analyzed, during which 41 
cell abnormalities were detected, ie 5.9% of the analyzed swabs. 
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Chart 5 shows the percentage of individual abnormalities out of the total 
detected cellular abnormalities. Most, with 41.46% or 17 findings for ASC - US, 16 
for HPV and 4 findings CIN1. The other abnormalities shown in the graph are 
present in a smaller percentage, and no invasive forms or cancer are detected. 
 
 
Chart 6 Review of the number of invited women, PAP tests made and discovered cell abnormalities 
during the 5 years of cervical cancer screening 
 
Chart 6 shows that the highest number of invited women was in 2017 and the 
lowest in 2020. Most PAP tests were performed in 2016 and the least in 2020. The 
small number of invited women and PAP tests performed in 2020 may be due to of 
the epidemiological situation with the Covid19 pandemic. Table 5 shows that the 
percentage of women who received an invitation but did not respond to an 
examination (30.5%) is the highest in 2020, which is probably due to the fear of 
patients with coronavirus infection, postponing all examinations that are not urgent, 
insulation and quarantine, etc. 
 


















2016 2017 2018 2019 2020




















































Jihe Zhu, Blagica Arsovska, and Kristina Kozovska 
 
International Journal of Research - GRANTHAALAYAH 255 
 
 
According to the results from the screening conducted during 5 years, from 
2016 - 2020 on the territory of Kocani, Vinica, Berovo, Pehchevo and Delchevo, the 
highest percentage of epithelial cell abnormalities were detected in the age group of 
36-45 years according to PAP tests performed in 2019. 
 
Ambulatory and dispensary morbidity from 2011-2020 
Diagnosis of cervical cancer is indicated by the code C53 - Malignant neoplasm 
of the cervix of the uterus. The following tables show the percentage of this 
diagnosis among the female population on the territory of Kocani, Vinica, Berovo, 
Pehchevo and Delchevo, in a period of 10 years. 
 
 
Graph 8 Display of the morbidity rate per 1000 women throughout 10 years 
  
On Graph 8 can be seen that per 1000 women, most infected are in Kocani 
during the period of all 10 years. In 2011, that number was the highest 5.4 / 1000 
or expressed as a percentage of 0.54% of the total number of women. That trend has 
declined, so the lowest rate is in 2020, ie. 1.6 / 1000. The number of patients in 
Vinica has been declining since 2014, when the rate was highest at 2.6. The curve 
for Pehchevo and Delchevo has numerous fluctuations, while for Berovo until 2014 
there is no information, following the curve recording two peaks and increasing 
from 2019. The CPH - Kocani has no data on the number of women who died from 
the disease and the mortality rate. 
Charts 9 and 10 show that most cases of malignant neoplasm of the cervix are 
in the age group of 50-54 years in terms of the total number of diagnosed cases and 
in relation to the total number of women of that age in 2011. Diagnosed cases in the 
age group of 25-34 years are detected every year only in Kocani, except for 2019 
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Chart 9 Percentage of patients by age in relation to the total number of cases 
 
 
Chart 10 Rate of ill woman in relation to the total number of women on that age 
 
4. CONCLUSION 
Cervical cancer remains one of the most common malignancies in the female 
population and in the world in general. Most new cases occur in developing 
countries, probably due to insufficient resources for prevention. In addition to most 
risk factors, persistent HPV infection is considered to be the main cause of the 
changes. The cervical cancer is potentially the most preventable and curable. 
Primary prevention consists of the HPV vaccine for the most common high-risk 
types of the virus, and secondary screening for PAP tests.  
According to the results of the research, in Macedonia, the coverage of 
screening should be increased and the registration should be regulated. In the early 
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